Studies by our group analyzed RKIP mRNA expression across 37 different cancer types and, using data from The Cancer Genome Atlas (TCGA) platform, showed that RKIP is downregulated in lung cancer compared to normal lung tissues, with lung adenocarcinoma being among the eight tumor types with the lowest RKIP expression levels [12]. This evidence concerns the gene PEBP1 and lung carcinoma.